Shannon Campbell

Director, Black Diamond Therapeutics, Inc.

Companies

Zentalis Pharmaceuticals, Inc.Board member May 27, 2026 to now¹
Black Diamond Therapeutics, Inc.Board member Apr 12, 2024 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zentalis Pharmaceuticals, Inc. ZNTL114,200 shares³$261.5K at $2.29May 26, 2026
Black Diamond Therapeutics, Inc. BDTX8,865 shares⁴$16.1K at $1.81Dec 13, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

May 26, 2026Granted 114,200 shares of Zentalis Pharmaceuticals, Inc.³
Dec 13, 2024Granted 4,500 shares at $2.50 of Black Diamond Therapeutics, Inc.⁴
Sep 20, 2024Granted 2,354 shares at $4.78 of Black Diamond Therapeutics, Inc.⁵
Jun 21, 2024Granted 2,011 shares at $4.98 of Black Diamond Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZentalis Pharmaceuticals, Inc., Board member
2
SEC EDGARBlack Diamond Therapeutics, Inc., Board member
3
SEC EDGARZentalis Pharmaceuticals, Inc. shares after the filing of May 26, 2026
4
SEC EDGARBlack Diamond Therapeutics, Inc. shares after the filing of Dec 13, 2024
5
SEC EDGARForm 4 filed Sep 20, 2024
6
SEC EDGARForm 4 filed Jun 21, 2024